Date: April 29-May 1, 2022
Accreditation: 17.5 CME/CE

Friday, April 29 – 8:00 AM-5:15 PM
Saturday, April 30 – 8:00 AM-5:15 PM
Sunday, May 1 – 7:30 AM-12:30 PM

The Spring Obesity Summit is designed to meet the attendee where they’re at in each individual area of obesity medicine. Hop between the Proficiency Track and Masters Track to personalize your learning experience while on-site.

2022 Spring Obesity Summit Tracks (please note, the Proficiency Track and Masters Track take place on Friday and Saturday only):

  1. Yellow = Proficiency Track
  2. Green = Masters Track

Schedule on Friday, April 29 (EDT)


  • 8:00-8:15 AM - Presidential Address

    Ethan Lazarus, MD

  • 8:15-9:15 AM - Keynote Session: Reset & Recharge: Discover Mindset & Productivity Habits That Reduce Stress, Burnout & Negativity, So You Can Enjoy Your Work & Life Again

    Betsy Allen Manning

    People are experiencing extreme levels of overwhelm, change fatigue & negativity in the workplace, which leads to conflict, low morale, low productivity, & added stress. It’s time to push the RESET button & RECHARGE your energy so you’re able to function at optimal performance, and truly enjoy your life and work again. In this highly interactive presentation, discover strategies for staying mentally strong, being productive without burnout, & how to keep a positive attitude no matter what challenges or changes you’re facing!

    Learning Obejectives:

    1. Discover 'CARE' technique to reduce stress & destroy negative thinking.

    2. Develop a ‘productive mindset’, and learn how to reduce burnout by prioritizing your day, identifying time stealers & eliminating the overwhelm that multiple projects can bring.

    3. Learn how to build your 'Work/Life Balance Strategy'

  • 9:30-10:30 AM - OMA Clinical Practice Statement Updates

    Harold Bays, MD, FOMA, Lydia Alexander, MD, FOMA, Karlijn Burridge, PA-C, Suzanne Cuda, MD

    Obesity Pillars is the peer review clinical journal of the Obesity Medicine Association. This presentation will describe the rationale behind the journal, types of articles accepted, editorial and review process, and brief instructions for authors. Finally, this presentation will give an overview of articles already published.

    Learning Obejectives:

    1. Discuss the rationale behind Obesity Pillars, the Obesity Medicine Association's society journal
    2.  Describe Obesity Pillars publication content and submission format of articles
    3. Summarize published Obesity Pillars articles, and how they apply to the clinical management of patients with obesity
  • 9:30-10:30 AM - Obesity and Obesity Paradox and Cardiovascular Disease

    Carl Lavie, MD

    This presentation will review the impact that obesity has on CVD Risk Factors and on CVD outcomes and mortality. The session will address the obesity paradox noted in patients with established CVD and the important role of physical activity (PA) and cardiorespiratory fitness (CRF) in this process. The potential role of weight loss strategies, especially efforts to improve PA, exercise training, and CRF, will be discussed.

    Learning Obejectives:

    1. Review the relationship between obesity and cardiovascular disease (CVD) risk factors and CVD outcomes
    2. Describe the obesity paradox noted in patients with established CVD
    3. Summarize the medical evidence demonstrating that treating obesity, especially with physical activity and exercise that improves fitness, lowers CVD risk and improves CVD outcomes
    4. Apply strategies to prevent and/or treat cardiovascular disease in patients with obesity
  • 10:30-11:15 AM - Incorporation of Very Low-Calorie Diet in Patient Care Setting

    Devika Umashanker, MS, MBA, MD

    This session will instruct clinicians in the clinical application of a Very Low- Calorie Diet (VLCD) as a treatment option for patients with obesity, including clinical circumstances in which the VCLD may be especially useful. The presentation will include relevant medical literature describing the benefits, limitations, and potential complications when prescribing a VLCD. Patient selection, evaluation, follow up, and transition to a less aggressive nutritional plan for long-term weight maintenance will also be discussed. The attendee will learn how to develop a comprehensive treatment plan that includes prescribing a VLCD (meal replacement vs real food, vitamins, minerals, and supplements), combined with behavioral interventions/patient education, physical activity, and the role of anti-obesity pharmacotherapy.

    Learning Obejectives:

    1. Describe the utility of a VLCD in patients with obesity including those with special circumstances (CKD, severe obesity, pre-operative surgical patients)
    2. Recognize the indications, limitations, and complications in patients treated with a VLCD
    3. Prescribe a VLCD nutritional treatment plan as part of a comprehensive obesity treatment program
    4. Describe the interdisciplinary team required to have successful VLCD program
    5. Describe weight loss outcomes and advantages of using a VLCD program utilizing either meal replacements, real food or a combination thereof
  • 10:30-11:15 AM - Obesity is a Risk Factor for Chronic Kidney Disease and Kidney Stones

    Ganesh Shidham, MD

    Obesity and bariatric surgery are a risk factor for kidney stones and chronic kidney disease. Prevalence of kidney stones is higher amongst patients with obesity (11.2%) vs patients with normal weight (6.1%). Bariatric surgery is effective for weight loss, however bariatric surgery is associated with increased risk of kidney stones (HR 4.1) and CKD (HR 1.96). Because of the concurrent epidemics of obesity, metabolic syndrome, and diabetes (all independently associated with increased risks of stone formation), current projections estimate costs due to kidney stone disease to rise by $1.24 billion per year by 2030. The underlying mechanism for kidney stone formation in patients with obesity is thought to be due to insulin resistance, dietary factors and lithogenic urinary risk profile. Insulin resistance alters renal acid-base mechanism, resulting in acidic urine pH and thus increasing risk for uric acid stones. Obesity is also associated with excess nutritional intake of lithogenic substances promoting calcium Oxalate stones. In addition, patients with bariatric surgery are associated with significant hyperoxaluria leading to calcium oxalate stones and oxalate nephropathy leading to progressive chronic kidney disease, at times needing dialysis.

    Learning Obejectives:

    1. Identify patients with obesity who are at risk for recurrent kidney stones
    2. Assess risk factors for recurrent kidney stone in patients with Bariatric surgery
    3. Discuss the evaluation, treatment, and prevention of kidney stones in patients treated for obesity
    4. Identify bariatric surgery patients with enteric hyperoxaluria leading to Oxalate nephropathy with worsening of kidney function
  • 12:45-1:45 PM - Top Ten Obesity Myths

    Angie Golden, DNP, FNP-C, FAANP

    This presentation will review the top ten obesity myths. Clinicians should be aware of these myths and be prepared to educate both patients and colleagues about the disease of obesity and evidence-based obesity treatments in order to dispel disinformation and misconceptions about obesity.

    Learning Obejectives:

    1. Recognize common myths about the disease of obesity
    2. List the process to overcome the myths
    3. Identify how myths can impact patients with obesity
    4. Explain evidence-based care for the treatment of obesity
  • 12:45-1:45 PM - Development and Validation of the 18-item Health Resilience Profile

    Stephen Herrmann, PhD

    Many people who seek treatment for obesity are able to lose weight; however, far fewer are able to successfully sustain the behavior changes required to maintain results long term. Psychological resilience is an individual’s capacity to negotiate, manage, and adapt to significant sources of stress or “bounce back” when confronted with significant physical or emotional experiences. Assessing and improving resilience may provide new opportunities to improve patient adherence and long-term results.

    Learning Obejectives:

    1. Describe psychological resilience and its role in weight management and health behavior change
    2. Understand key psychometric evaluation processes to creating and testing scales and instruments
    3. Apply basic techniques to evaluate and manage patients more effectively through behavioral change
  • 1:45-2:45 PM - Obesity & Black Women: What Are We Missing?

    Sylvia Gonsahn-Bollie, MD

    According to recent CDC data, African American women have the highest rate of obesity. Four out of five Black women are overweight or have obesity. Despite these high rates of overweight and obesity, disparities exist in obesity reduction behaviors and obesity interventions in African American women. This thought-provoking session, will include interactive didactic teaching methods as well as case-based learning (CBL) to go beyond the epidemiological data and explore best practices to enhance treatment of obesity in African American women.

    Learning Obejectives:

    1. Identify the appropriate adjusted BMI for Black women based on race, ethnicity, age, and obesity related conditions
    2. Contextualize potential contributing factors to obesogenic energy imbalance in Black women that may interfere with obesity treatment and management
    3. Describe the role body confidence plays in discussing patient's obesity diagnosis and managing treatment expectations
    4. Identify additional screening tools for obesity beyond BMI that can assist with individualized obesity screening
    5. Discuss the racial disparities in obesity treatment for African American women
  • 1:45-2:45 PM - Improving Physical Activity in People with Obesity and Physical Limitations

    Michelle Look, MD, FAAFP

    The health consequences of obesity can create significant barriers to physical activity. This session will address evaluating patient physical limitations caused by obesity. By developing strategies to adapt to physical limitations and design individual activity plans providers can help patients work with their limitations to develop an effective physical activity plan.

    Learning Obejectives:

    1. Describe common conditions that limit activity in people with obesity
    2. Identify patients who need exercise stress testing before physical activity
    3. Develop an exercise prescription 
    4. Develop practical exercise recommendations for individual with activity limitations
  • 3:15-4:15 PM - The Essentials of Anti-Obesity Medications - A Case-Based Approach

    Jennifer Seger, MD, FOMA, ABFM, ABOM

    This session includes a variety of short case presentations that involve pharmacotherapy in obesity medicine. Utilizing polling, participants will identify medications that may be contributing to weight gain and strategies that may eliminate or mitigate their weight promoting effects. These case scenarios will also provide interactive opportunities to select the most appropriate anti-obesity pharmacotherapy based on factors including co-morbidities, contraindications, drug combinations, concurrent therapy, and cost.

    Learning Obejectives:

    1. Explore underlying causes of obesity in individual patients through interactive case presentations
    2. Recognize factors or circumstances in each case scenario that may influence the choice of a safe and effective anti-obesity medication and/or strategies to mitigate the effect of weight promoting medications
    3. Develop strategies that optimize weight loss and/or improve or reverse obesity-related disease by means pharmacological interventions
  • 3:15-4:15 PM - Treatment Strategies for Obesity Before After and During Pregnancy

    Carolynn Francavilla, MD

    The majority of women in the US will experience a pregnancy in their lifetime. Unfortunately, the treatment of obesity is, too often, not considered when preparing for and managing pregnancy or the postpartum period. In this lecture, we will discuss obesity treatment at various stages of a women’s reproductive life cycle. We will explore the importance of obesity management at each stage and provide key recommendations. We will discuss unique medication considerations, appropriate nutrition strategies, exercise guidelines, and special behavior change considerations. Participants will be able to apply practical strategies to treat women who are preparing for pregnancy, are pregnant, or are postpartum.

    Learning Objectives:

    1. Recognize the importance of obesity management before, after, and during pregnancy
      Identify safety considerations for medications preconception, in pregnancy, and during breastfeeding
      Apply appropriate dietary strategies for women before, after, and during pregnancy
  • 4:15-5:15 PM - Managing Obesity-Related Complications

    Sandra Christensen, MSN, ARNP, FNP-BC, FOMA

    In this interactive presentation utilizing complex real-life cases followed over several years, the attendees will learn how to treat obesity-related complications in a manner that optimizes obesity treatment and improves outcomes. Participants in this activity will be guided through the process of developing individualized treatment plans based on the underlying pathophysiology of the complications a patient presents with. The presentation will address how to choose nutritional interventions, physical activity programs, behavioral interventions, select appropriate medications, and make referrals based on the specific needs of individual patients. Complex real-life cases will demonstrate how to implement an individualized stepwise comprehensive treatment plan that improves both obesity and its complications. These cases will follow patients for several years, demonstrating the chronic nature of obesity, the impact of complications, and how effective treatment improves both current and future health.

    Learning Obejectives:

    1. Describe the pathophysiologic mechanisms by which excess adiposity causes obesity-related complications
    2. Identify and evaluate obesity-related complications that may require treatment and/or referral
    3. Develop an individualized, stepwise, comprehensive treatment plan based on a patient’s obesity-related complications
  • 4:15-5:15 PM - Multidisciplinary Panel Discussion on Complex Patient Cases

    Catherine Varney, DO, ABOM, Timothy Garvey, MD, FACE, MABOM and Kenneth Resnicow, PhD

    This session will have three presentations diving into a particular patient case. They will each focus on a separate complex case providing insight on how to handle and treat that unique patient.

    Learning Objectives:

    1. Describe normal physiological changes that occur with menopause
    2. Explain how normal physiological changes can lead to overweight or obesity
    3. Predict abnormalities and design treatment plans to prevent or minimize weight gain following menopause based on these changes
    4. Appreciate the importance of “harmonizing” treatment goals with patients
    5. Elucidate strategies for promoting ongoing adherence to treatment plans
    6. Understand the physiological basis for equilibration of weight loss following weight loss interventions
    7. Learn how to use reflective responses to handle intense patient emotion
    8. Learn how to use affirmation
    9. Understand and apply the Elicit Provide Elicit technique

Schedule on Saturday, April 30 (EDT)


  • 8:00-9:00 AM - Keynote Session: Intermittent Fasting - DeMystified

    Jason Fung, MD

    This talk reviews the physiology of what happens to the human body during fasting, and how that applies to weight loss. Attendees will learn about the role of insulin and counter regulatory hormones, and the regulation of energy storage including de novo lipogenesis and lipolysis. This presentation will reconcile the hormonal view of obesity with the caloric view, and demonstrate intermittent fasting as an efficient strategy to affect both. Recent randomized controlled studies on intermittent fasting will be reviewed.

    Learning Obejectives:

    1. Review the physiology of fasting
    2. Discuss recent fasting trials
    3. Understand how fasting may help weight loss and improve adiposity related disease
  • 10:00-11:00 AM - The Role of Physical Activity in Weight Maintenance and Health

    Tim Church, MD, PhD, MPH

    This presentation will address the clinical evidence regarding the role of physical activity (PA) for maintaining weight loss and improving cardiometabolic and other heath parameters. This session will also address how much and which type of PA is best for optimizing weight maintenance and health, and whether PA adds additional benefits to nutritional interventions alone. The attendees will learn about various tools and strategies to assist patients to incorporate and maintain a regular PA routine.

    Learning Obejectives:

    1. Summarize the medical evidence for incorporating PA as a critical component for weight management and health in patients with obesity
    2. Review the type and quantity of PA to optimize weight maintenance and cardiometabolic health
    3. Identify tools and strategies to incorporate and maintain PA in patients for the prevention of weight regain and weight maintenance
  • 10:00-11:00 AM - Nutrition and Cancer

    Jason Fung, MD

    This lecture focuses on the tight link between nutrition and cancer. It is estimated that about 30% of the risk of cancer can be attributed to diet, which is just below tobacco smoke and far, far above any other known risk factor. But what part of the diet is the culprit? For decades, the answer was unknown, but recent data from the last 20 years points directly to obesity and hyperinsulinemia as the primary culprit.

    Learning Obejectives:

    1. Recognize the epidemiology of obesity related cancer
    2. Explore the pathophysiology of the relationship between obesity and cancer
    3. Examine the data on the contribution of nutritional intake and nutritional supplements in causing or preventing cancer
  • 11:00 AM-12:00 PM - Disordered Eating in Pediatric Obesity: What to Do and How to Help?

    Eileen Chaves, PhD and Nicole Greenwood, MD

    Disordered eating behaviors are higher among children and adolescents with obesity compared to their typical-weight peers. Not only does disordered eating impact children and adolescents with obesity's health-related quality-of-life, but it also often affects treatment outcomes. Understanding how disordered eating presents in children and adolescents is critical to helping patients and families remain engaged in treatment, provide best practice clinical care, and help patients feel heard and understood. This session will help providers better understand the differences between disordered eating and eating disorders, how to assess for both, offer practical treatment interventions for disordered eating, and help providers know when and how to refer to specialty care for additional treatment. Using case-based learning, the presenters will illustrate how to practically recognize and assess for disordered patterns of eating in children and adolescents with obesity, as well as discussing treatment interventions that can be used during medical visits. The medical, psychological, and quality-of-life health impacts of disordered eating on children and adolescents with obesity will also be discussed.

    Learning Obejectives:

    1. Describe different types of disordered eating frequently seen in children and adolescents with obesity
    2. Differentiate between disordered eating and eating disorders in children and adolescents with obesity
    3. Identify behavioral approaches used to treat disordered eating in children and adolescents with obesity
    4. Recognize when to refer to behavioral health and/or eating disorder specialists for continued treatment
    5. Explain how to screen for eating disorders in children and adolescents with obesity
  • 11:00 AM-12:00 PM - Future Advances in Anti-Obesity Medications

    Louis Aronne, MD, FACP, DABOM

    Learning Objectives:

    1. Describe current metabolic targets of anti-obesity medications
    2. Identify key future metabolic targets of anti-obesity medications
    3. Discuss the status of promising future anti-obesity medications and their role in obesity treatment
  • 1:30-2:30 PM - Sleep and Obesity: Why You Should be Cognizant of the Two

    Ruchir P. Patel, MD, FACP

    The relationship between sleep and obesity is well known. The prevalence of sleep disorders and obesity are ever increasing in our population. As obesity medicine specialists it is critical to be aware of the need to evaluate a patient with obesity for sleep disorders. There are grave health consequences with untreated sleep disorders and not identifying sleep disorders may hinder the patient’s ability to successfully lose weight.

    Learning Obejectives:

    1. Describe the relationship between obesity and sleep
    2. Discuss the health consequences of obstructive sleep apnea
    3. Identify the impact of weight loss on obstructive sleep apnea and the associated health benefits
    4. Describe current treatment options for obstructive sleep apnea
    5. Review how a sleep specialist applies treatment options in the management of obstructive sleep apnea
  • 1:30-2:30 PM - Management of Peri & Postmenopausal Weight Gain

    Cate Varney, DO, ABOM

    In 2020, the U.S. Census Bureau released estimates showing the 65-and-older population has grown rapidly since 2010. The growth of this population contributed to an increase in the national median age from 37.2 years in 2010 to 38.4 in 2019. Within these numbers, women make up a majority percentage. This percentage only continues to grow as they age within this group. This is the fastest rising age group and obesity specialists must be prepared to take care of this population. Additionally, a growing number of patients are seeking bariatric surgery and there is known significant risk of weight gain following surgery. As this post-bariatric surgery population ages, we must also understand how menopause will increase their risk of weight regain after loss. With this knowledge, we can better assist our patients through all stages of their life with weight management.

    Learning Obejectives:

    1. Describe normal physiological changes that occur with menopause
    2. Explain how the normal physiological changes can lead to overweight or obesity
    3. Predict abnormalities and design treatment plans to prevent or minimize weight gain following menopause based on these changes
  • 2:30-3:30 PM - Cultural Considerations for Treating Asians with Abdominal Obesity

    Jill Ratanaphruks, MSN, FNP-BC

    This session will address cultural considerations for diagnosis and treatment of obesity and adiposity-related disease among those of Asians descent living in the US. Although this population includes a number of ethnic and culturally diverse subgroups, this presentation will focus primarily on those from India and Southeast Asia, China, Korea, and the Pacific Islands. Persons of Asian heritage have a high risk of developing complications of obesity including type 2 diabetes and CVD at a lower BMI than other populations. Attendees will learn the diagnostic criteria for obesity in this group aa well as culturally sensitive treatment and dietary plans that can be applied to various subsets within the Asian population living in the U.S.

    Learning Obejectives:

    1. Define the scope of obesity and its consequences in the Asian population
    2. Define BMI and waist circumference using population specific guidelines
    3. Describe examples of several Asian diets and list one culturally relevant treatment recommendation for each diet
    4. Summarize two culturally relevant interventions for behavior within an Asian sub-population
  • 2:30-3:30 PM - Prescriptive Nutritional Intervention using Meal Replacements: Evidence and Case Based Practical Approaches

    Angela Fitch, MD

    Learn the evidence for use of meal replacements and medically tailored meals in the treatment of obesity and related adiposity related complications. Apply to use of meal replacements to patients with complicated medical diseases (heart failure, diabetes, kidney failure) and in various care settings (group homes, telemedicine, virtual groups, partial meal replacements and VLCD).

    Learning Obejectives:

    1. Summarize the clinical evidence for meal replacements for the treatment of obesity and ARD’s
    2. Describe the value of MR in multiple weight management contexts: weight loss, weight loss maintenance, treatment of chronic diseases, and in the treatment of weight regain
    3. Prescribe MR as a strategy for treating obesity and ARD’s
  • 4:00-5:15 PM - Tailoring a Nutrition Plan to Your Patient

    Ethan Lazarus, MD, FOMA and Erin Winchester, RDN 

    There are multiple factors that should come into play when establishing a nutrition plan for a patient. Past successes, patient preferences, and underlying health conditions should all be considered in the planning process. This session will review different dietary options and explore the process of working with patients to develop a tailored dietary intervention. Obesity treatment benefits from a teamwork approach. This session will include participation of a registered dietician who will describe how RD's work with patients in a team-based strategy to develop an individualize nutrition plan.

    Learning Obejectives:

    1. Review common nutritional interventions for weight management
    2. Describe patient-centered strategies for developing a nutrition plan
    3. Utilize a teamwork approach in developing a tailored dietary intervention
  • 4:15-5:30 PM - Applying Precision Medicine in Choosing an Anti-obesity Medication: A case-based approach

    Andres Acosta, MD, PhD

    There is a marked variation in individual patient response to interventions designed to treat obesity and adiposity related diseases. The heterogenicity in obesity treatment response is not surprising when considering the numerous underlying factors that contribute to adiposity and associated conditions. This session will use case presentations to demonstrate how identifying patient phenotypic subgroups when choosing an anti-obesity agent, can improve clinical outcomes in patients treated for obesity.

    Learning Obejectives:

    1. Review the current literature pertaining to identifying and treating patients with obesity utilizing individual phenotypes
    2. List the obesity phenotypic subgroups
    3. Describe how anti-obesity medications affect treatment outcome based on the obesity phenotype
    4. Choose the most appropriate anti-obesity pharmacotherapy based upon a patient’s phenotypic characteristics

Schedule on Sunday, May 1 (EDT)


  • 7:15-8:15 AM - Breakfast with the Experts

    Choose a table with a topic that interests you and spend breakfast discussing that topic with an expert and a small group of other clinicians. Topics coming soon!

    *This event is worth 0.75 CME/CE credits. In addition to class sessions, attendance at this event is required to earn the full 17.5 CME/CE credits for the Spring Obesity Summit.

  • 8:30-9:30 AM - Complexity of Obesity, Diabetes and Depression: Which One to Address First?

    Nowreen Haq, MD, MPH, FACP, FACE

    In this session, participants will learn to address the role of depression in worsening the outcomes in patients with obesity, insulin resistance, and type 2 diabetes. This presentation will review the complex pathophysiologic pathways involved, and interventional strategies to simultaneously manage depression, obesity, insulin resistance and type 2 diabetes.

    Learning Obejectives:

    1. Discuss the role of depression in patients with obesity, insulin resistance, and type 2 diabetes
    2. Prescribe effective treatment strategies to address the multifactorial complexities of depression, obesity and diabetes
    3. Apply cognitive behavioral skills in the active management of depression, obesity and diabetes
  • 9:30-10:30 AM - Obesity Billing, Coding & Reimbursement: Get Paid for the Work that You Do

    Katie Queen, MD, FAAP, Diplomate of ABOM

    This is a case-based interactive session highlighting practical strategies for choosing the appropriate ICD11 (coming Jan 2022) Diagnostic Codes for Obesity & Weight Related Comorbidities, along with a discussion of how to choose a level of service for Evaluation and Management of Obesity. We will highlight both provider codes and dietician/psychologist codes that can be used for weight management. Coding and billing for telehealth, along with billing for remote patient monitoring will also be addressed. Included in this presentation is a review of the current state of reimbursement for obesity care at the national level, along with a case study of how we used a survey to state payors for obesity related services to advocate for improved coverage of obesity treatment in our state.

    Learning Obejectives:

    1. Appropriately use ICD Diagnostic Codes & Evaluation and Management Professional Codes for obesity related care
    2. Understand the state of obesity care coverage and reimbursement at both a national and state level
    3. Gain confidence in their ability to advocate for better reimbursement for obesity related services in their state
  • 10:45-11:30 AM - Use of Telehealth in Obesity Management: Current Evidence and Future Directions

    John Batsis, MD

    This talk will provide an overview of the patterns of telehealth (telemedicine and remote monitoring) use in the past decade and identify the currently available tools and technologies that can be used in managing patients with obesity. The lecture will review the barriers and facilitators to using telehealth modalities and touch upon the specific patients and practice settings which it can be best implemented in.

    Learning Obejectives:

    1. Review the advantages and limitations of remote patient monitoring for treating and managing patients with obesity
    2. Summarize the currently available tools and technologies relevant in treating and managing patients with obesity
    3. Identify which patients and practice settings could benefit by utilizing remote monitoring
  • 11:30 AM-12:30 PM - Stop Weight Bias

    Joe Nadglowski

    Weight bias is prevalent in many areas of life for someone with obesity; however, healthcare is one of the most prevalent. In fact, more than 10% of individuals in the U.S. have experienced weight bias in healthcare according to an OAC survey. From exam room equipment to language-use, people with obesity face a myriad of bias when working with healthcare professionals. OAC will use this opportunity to showcase examples of weight bias in healthcare and ways to avoid it.

    Learning Obejectives:

    1. Discuss the importance of people-first language for obesity
    2. Recognize instances of weight bias in healthcare
    3. Explore the patient perspective on weight bias in healthcare and other areas of life